Nivolumab/pembrolizumabVarious toxicities: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1734卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56504-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：379 / 379

相关论文

共 50 条

[31] Nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2021, 1863 (1) : 278 - 278
[32] Nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2020, 1799 (1) : 295 - 295
[33] Nivolumab/pembrolizumabVarious toxicities: 7 case reports
Reactions Weekly, 2020, 1802 (1) : 225 - 225
[34] Nivolumab/pembrolizumabVarious toxicities: 16 case reports
Reactions Weekly, 2019, 1770 (1) : 313 - 313
[35] Nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2022, 1918 (1) : 392 - 392
[36] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 14 case reports
Reactions Weekly, 2022, 1907 (1) : 271 - 271
[37] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 29 case reports
Reactions Weekly, 2021, 1859 (1) : 201 - 201
[38] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 18 case reports
Reactions Weekly, 2023, 1957 (1) : 315 - 315
[39] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1929 (1) : 360 - 360
[40] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2019, 1751 (1) : 221 - 221

← 1 2 3 4 5 →